Business Standard

Indoco Remedies zooms over 30% in two-days on strong Q1 earnings

The stock surged 17% to Rs 256, extending its previous day's 14% rally on the National Stock Exchange.

SI Reporter Mumbai
Indoco Remedies has surged 17% to Rs 256, extending its previous day’s 14% rally, after reported an over two-fold jump in net profit at Rs 20 crore for the first quarter ended June 2014 (Q1), on back of strong operational performance. The pharmaceuticals company had profit of Rs 9 crore in the same quarter last fiscal.

The company’s net sales grew 29% to Rs 199 crore during the quarter under review against Rs 154 crore in the corresponding quarter of previous year.

The growth was driven by both exports and domestic, which posted a year-on-year (yoy) growth of 58.8% and 23.1% respectively. The domestic formulation sales grew by 24.4% yoy, much higher than the Industry growth of 8.8% yoy.

On the operating front, the OPM’s came in 18.1% V/s 16.2% expected and an expansion of 560 basis points yoy, mainly on back of the gross margins, which expanded by 365 basis points yoy to end the period at 63.3% V/s 59.7% during the last corresponding period, says analyst at Angel Broking in a client note.

The stock opened at Rs 219 and touched a record high of Rs 259 on NSE. The trading volumes on the counter surged more than two-fold with a combined 3.13 million shares changed hands so far on NSE and BSE.
 
 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 31 2014 | 2:42 PM IST

Explore News